Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 38.15 CNY 3.05% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qingdao NovelBeam Technology Co Ltd
Other Current Liabilities Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Other Current Liabilities
ÂĄ24.5m
CAGR 3-Years
26%
CAGR 5-Years
37%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Current Liabilities
ÂĄ331.4m
CAGR 3-Years
105%
CAGR 5-Years
109%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Current Liabilities
ÂĄ587.7m
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
30%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Current Liabilities
ÂĄ5B
CAGR 3-Years
13%
CAGR 5-Years
19%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Current Liabilities
ÂĄ318.2m
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Current Liabilities
ÂĄ3B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Qingdao NovelBeam Technology Co Ltd's Other Current Liabilities?
Other Current Liabilities
24.5m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Other Current Liabilities amounts to 24.5m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
37%

Over the last year, the Other Current Liabilities growth was -65%. The average annual Other Current Liabilities growth rates for Qingdao NovelBeam Technology Co Ltd have been 26% over the past three years , 37% over the past five years .

Back to Top